TABLE 4.
Node (miRNA/canonical pathway) | Connectivity degree | Activity |
---|---|---|
mmu-let-7b-5p | 16 | ↓↑ |
mmu-let-7a-5p | 14 | ↓↑ |
mmu-let-7c-5p | 10 | ↓↑ |
mmu-miR-106b-3p | 8 | ↑↓ |
mmu-let-7g-3p | 3 | ↓↑ |
mmu-let-7g-5p | 1 | ↓↑ |
mmu-miR-1247-5p | 1 | ↑↓ |
mmu-let-7b-3p | 1 | ↓↑ |
mmu-miR-674-5p | 1 | ↑↓ |
NRF2-mediated Oxidative Stress Response | 4 | ↑↓ |
IL-8 Signaling | 4 | ↑↓ |
Leukocyte Extravasation Signaling | 4 | ↑↓ |
Neuroinflammation Signaling Pathway | 3 | ↑↓ |
Tec Kinase Signaling | 3 | ↑↓ |
iCOS-iCOSL Signaling in T Helper Cells | 3 | ↑↓ |
Th1 and Th2 Activation Pathway | 3 | — |
Xenobiotic Metabolism Signaling | 3 | — |
Th1 Pathway | 2 | ↑↓ |
CD28 Signaling in T Helper Cells | 2 | ↑↓ |
PXR/RXR Activation | 2 | — |
PD-1, PD-L1 cancer immunotherapy pathway | 2 | ↓↑ |
RhoGDI Signaling | 2 | ↓↑ |
Fc Receptor-mediated Phagocytosis in Macrophages and Monocytes | 2 | ↑↓ |
T Helper Cell Differentiation | 2 | — |
Hepatic Fibrosis/Hepatic Stellate Cell Activation | 2 | — |
Natural Killer Cell Signaling | 2 | — |
Agranulocyte Adhesion and Diapedesis | 1 | — |
Atherosclerosis Signaling | 1 | — |
FXR/RXR Activation | 1 | — |
Signaling by Rho Family GTPases | 1 | ↑↓ |
Role of NFAT in Regulation of the Immune Response | 1 | ↑↓ |
Phagosome Formation | 1 | — |
Granulocyte Adhesion and Diapedesis | 1 | — |
Connectivity degree, the number of edges between two nodes; up- or down-ward arrow, a MicroRNAs or a canonical pathway is up- or down-regulated; short horizontal line, the activity of a pathway is unkown. p < 0.05.